Small Molecule Modulators of AMP-Activated Protein Kinase (AMPK) Activity and Their Potential in Cancer Therapy

Area of Science:

• Biochemistry
• Cellular Metabolism
• Oncology

Background:

• AMP-activated protein kinase (AMPK) is a key regulator of cellular energy homeostasis, activated by low ATP levels.
• AMPK influences both anabolic and catabolic pathways to restore cellular energy balance.
• AMPK plays a dual role in cancer, acting as a tumor suppressor or promoting cancer cell survival.

Purpose of the Study:

• To review the multifaceted role of AMPK in cancer development and drug resistance.
• To discuss the impact of the tumor microenvironment on AMPK signaling.
• To summarize current strategies for developing AMPK activators and inhibitors for cancer therapy.

Main Methods:

• Literature review and synthesis of existing research on AMPK in cancer.
• Analysis of preclinical data on small molecule AMPK modulators.
• Discussion of emerging concepts in AMPK isoform-selective targeting.

Main Results:

• Small molecule AMPK activators and inhibitors have shown efficacy in preclinical cancer models.
• The tumor microenvironment significantly influences AMPK activity in cancer cells.
• Isoform-selective targeting of AMPK presents a promising therapeutic avenue.

Conclusions:

• AMPK is a critical therapeutic target in oncology with potential for both tumor suppression and modulation of cancer cell survival.
• Understanding AMPK's role in the tumor microenvironment is crucial for effective therapeutic development.
• Targeted approaches, including isoform selectivity, are key to optimizing AMPK-based cancer treatments.